These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 24884809

  • 1. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L.
    Mol Cancer; 2014 May 31; 13():133. PubMed ID: 24884809
    [Abstract] [Full Text] [Related]

  • 2. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
    Wang J, Zheng T, Chen X, Song X, Meng X, Bhatta N, Pan S, Jiang H, Liu L.
    J Gastroenterol Hepatol; 2011 Feb 31; 26(2):371-7. PubMed ID: 21261729
    [Abstract] [Full Text] [Related]

  • 3. Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
    Zheng T, Wang J, Song X, Meng X, Pan S, Jiang H, Liu L.
    J Cancer Res Clin Oncol; 2010 Oct 31; 136(10):1597-604. PubMed ID: 20174822
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y, Jiang F, Liu Q, Shen J, Wang X, Li Z, Zhang J, Lu X.
    Toxicol Sci; 2015 Jan 31; 143(1):156-64. PubMed ID: 25304214
    [Abstract] [Full Text] [Related]

  • 9. Much ado about Nutlin.
    Teoh NC.
    J Gastroenterol Hepatol; 2011 Feb 31; 26(2):213-5. PubMed ID: 21261708
    [No Abstract] [Full Text] [Related]

  • 10. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.
    Liu X, Gao X, Yang Y, Yang D, Guo Q, Li L, Liu S, Cong W, Lu S, Hou L, Wang B, Li N.
    Apoptosis; 2024 Aug 31; 29(7-8):1161-1184. PubMed ID: 38743191
    [Abstract] [Full Text] [Related]

  • 11. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
    Chen X, Zhang M, Liu LX.
    Oncol Rep; 2009 Jul 31; 22(1):73-80. PubMed ID: 19513507
    [Abstract] [Full Text] [Related]

  • 12. Nutlin-3 downregulates p53 phosphorylation on serine392 and induces apoptosis in hepatocellular carcinoma cells.
    Shi X, Liu J, Ren L, Mao N, Tan F, Ding N, Yang J, Li M.
    BMB Rep; 2014 Apr 31; 47(4):221-6. PubMed ID: 24286312
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.
    Yan W, Zhang Y, Zhang J, Liu S, Cho SJ, Chen X.
    J Biol Chem; 2011 May 20; 286(20):17478-86. PubMed ID: 21454520
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.
    Zhang KZ, Zhang QB, Zhang QB, Sun HC, Ao JY, Chai ZT, Zhu XD, Lu L, Zhang YY, Bu Y, Kong LQ, Tang ZY.
    J Hematol Oncol; 2014 Mar 30; 7():28. PubMed ID: 24678763
    [Abstract] [Full Text] [Related]

  • 16. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar 30; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 17. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J.
    Oncotarget; 2016 Oct 25; 7(43):70504-70515. PubMed ID: 27655700
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.
    Zhang X, Jia S, Yang S, Yang Y, Yang T, Yang Y.
    J Cell Biochem; 2012 Nov 25; 113(11):3528-35. PubMed ID: 22730174
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
    Wang GZ, Zhang W, Fang ZT, Zhang W, Yang MJ, Yang GW, Li S, Zhu L, Wang LL, Zhang WS, Liu R, Qian S, Wang JH, Qu XD.
    J Cancer Res Clin Oncol; 2014 Jul 25; 140(7):1125-36. PubMed ID: 24756364
    [Abstract] [Full Text] [Related]

  • 20. [The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Liu LX, Zhu AL, Chen W, Guo HX, Wang XQ, Liu ZH, Zhang TD, Jiang HC, Wu M.
    Zhonghua Wai Ke Za Zhi; 2005 Jan 01; 43(1):33-6. PubMed ID: 15774171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.